Short answer
A test of cure retests after treatment to verify organism clearance. Distinct from reinfection screening, which watches for new exposures later.
Guidelines reserve it for specific infections and situations rather than universal use, schedule it past residual-DNA windows to avoid false positives, and interpret persistence through the treatment-failure-versus-reinfection distinction only full histories resolve.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →Test-of-cure versus neighbors
| Retest type | Question answered | Typical timing |
|---|---|---|
| Test-of-cure | Did treatment clear this infection? | Scheduled post-treatment interval |
| Reinfection screen | Did new exposure reintroduce infection? | Risk-driven ongoing schedule |
| Titer monitoring | Is serologic response on track? | Months-long syphilis-style arcs |
| Symptom-driven return | Why do symptoms persist? | Immediately on presentation |
Timing companion: STI Reinfection vs Treatment Failure.
Care pathway: Follow-Up Testing After STI Treatment Guide.
Making test-of-cure work
- Follow the scheduled interval exactly. Early testing manufactures confusion, not reassurance.
- Complete partner treatment first. Retesting into an untreated-partner loop proves nothing.
- Abstain through the window plus directed margins so new exposures never muddy verification.
- Bring full treatment records. Regimens, dates, adherence, and partner status shape interpretation.
Test-of-cure controversies and nuances
Test-of-cure debates center on scope: universalists favor verification for all treated infections (certainty maximalism), minimalists reserve it for guideline-specified situations (resource stewardship), with most practice occupying evidence-based middle ground following organism-specific recommendations.
NAAT hypersensitivity complicates absolutism. Residual DNA detection without viable organisms argues against indiscriminate retesting as much as for selective verification.
Pregnancy, HIV co-infection, and complicated courses expand test-of-cure indications legitimately, while straightforward uncomplicated cases in adherent patients with treated partners often resolve without verification per guidelines.
Nuance beats slogans: follow organism-specific, situation-specific recommendations rather than universal rules in either direction.
Guidelines encode the balance; clinicians apply it.
Pregnancy test-of-cure specifics
Pregnancy elevates test-of-cure from optional to essential across more infections: vertical-transmission stakes demanding verified clearance (not assumed cure), delivery planning depending on documented status, and neonatal prophylaxis protocols keyed to maternal clearance confirmation.
Prenatal test-of-cure schedules run earlier and more comprehensively than general-population equivalents.
Coordinate obstetrically: results routed directly to prenatal records (not general portals alone), positive findings triggering enhanced surveillance protocols automatically, and partner co-treatment verified before delivery approaches.
Pregnancy compresses every timeline while raising every stake. Test-of-cure discipline matters most exactly where delay costs most.
Verify clearance; protect newborns.
When to seek care
Now if a result is positive or indeterminate. Confirmatory and treatment pathways start immediately, not after deliberation.
On schedule for window-based rechecks, and promptly for any symptom contradicting paperwork.